請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/4744
標題: | 質子放射治療設備系統經營策略之個案研究 A Case Study of Business Strategy on Proton Radiotherapy Apparatus System |
作者: | Chi-Yen Yin 尹其言 |
指導教授: | 洪一薰 |
關鍵字: | 高階醫療系統,質子放射治療,經營策略, advance medical system,proton beam radiotherapy,business strategy, |
出版年 : | 2015 |
學位: | 碩士 |
摘要: | 儘管現代醫學治療已經取得良好的進展,癌症治療仍然是現今最重要的研究議題之一。與傳統放射治療法比較,質子放射治療法針對惡性腫瘤提供一個相對高有效性與符合經濟效益的治療方法。
本研究目的是(1)檢視全球高階醫療系統之產業發展脈絡和商業模式;(2)了解全球質子放射治療設備製造商經營規劃與未來策略布局;(3)探索臺灣個案公司進入新興市場可預見之商業機會與困難障礙。 本研究以個案研究法對質子放射治療設備生產廠商進行研究,採用深度訪談法對臺灣企業高階主管以半結構性訪談方式進行調查,以利研究資料的蒐集。以醫療法規、產業政策和專利技術三項構面進行觀察,並對個案公司提出剴切建議以及未來可能之發展方向。 研究分析得知,質子放射治療法為目前全世界最先進之腫瘤放射治療技術,可以快速消滅惡性腫瘤細胞並降低人體正常組織因治療所受到的傷害。質子放射治療設備是一種高階醫療系統,其組成包含:(a)能量選擇系統;(b)醫用加速器系統;(c)射束傳導系統;(d)射束形成系統;(e)旋轉機座系統;(f)病患定位系統和(g)機器手臂治療床。 研究結果發現,個案公司發展質子放射治療設備具有下列優勢:(1)製造模組化整合能力;(2)醫療排程和資訊管理;(3)先進臨床治療系統;(4)高性價比客製化產品與(5)平價癌症醫療服務。 研究結論歸納,個案公司的經營策略是自有品牌推廣、核心技術競爭力強化與質子放射治療醫學教學中心設置,並將整套高階醫療系統憑藉「建置-營運-轉移」模式直接輸入至中國大陸、東南亞、拉丁美洲以及非洲等新興市場。其關鍵決定因素是(a)啟動計畫資金籌措;(b)大型場地空間取得;(c)醫療等級營建技術以及(d)與區域醫療院所策略聯盟。 Despite the progress that has been achieved using modern methods of therapy, cancer currently remains one of the greatest problems within medicine. Proton radiotherapy is one of the most economical methods of treatment for malignant diseases with a relatively high rate of effectiveness. This study aims to examine (1) a worldwide industrial development general view on advanced medical systems; (2) the evolution of global proton beam therapy; (3) how Taiwanese enterprise will be at forefront of delivering the last innovative cancer therapy to emerging markets. Case study methodology was conducted for this interview survey with CEO of biomedical technology incorporation in Taiwan. Medical regulations, industrial policies, and technology patents were observed as three principals in this investigation. Proton beam therapy is an rising form of radiation therapy that can maximize radiation doses to the target tumor, while sparing adjacent healthy tissues. Proton beam radiotherapy apparatus is one of robust radiation oncology technologies which comprising (a) energy selection system; (b) medical accelerator system; (c) beam delivery system; (d) beam output system; (e) gantry system; (f) patient positioning system and (g) robotic couch. Results reveal that the strengths of biomedical technology incorporation are (1) integrated modularized manufacturing ability; (2) medical treatment scheduling and information management; (3) advanced clinical curing system; (4) cost-effective customized products and (5) affordable cancer therapy services. The findings were summarized as the following statements; the business strategy encompasses three dimensions: branding promotion, core technology competence strengthening, and proton radiotherapy medical education hub network establishment. The entire advanced medical system can be conveyed to emerging markets based on“build-operate-transfer”model; the major determinants are (a) initial fundraising management; (b) larger size facility acquired; (c) medical criterion constructing techniques; and (d) strategic alliance with regional hospitals. |
URI: | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/4744 |
全文授權: | 同意授權(全球公開) |
顯示於系所單位: | 工業工程學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-104-1.pdf | 3.87 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。